Literature DB >> 32433719

Coronavirus Disease 2019 (COVID-19) and Immune-Engaging Cancer Treatment.

Muhammad Bilal Abid1,2, Mustafa Mughal3, Muhammad Abbas Abid4.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32433719     DOI: 10.1001/jamaoncol.2020.2367

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN: 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  11 in total

Review 1.  Infectious complications, immune reconstitution, and infection prophylaxis after CD19 chimeric antigen receptor T-cell therapy.

Authors:  Kitsada Wudhikarn; Miguel-Angel Perales
Journal:  Bone Marrow Transplant       Date:  2022-07-15       Impact factor: 5.174

2.  Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists.

Authors:  Margaret Ottaviano; Marcello Curvietto; Pasquale Rescigno; Marianna Tortora; Giovannella Palmieri; Diana Giannarelli; Michele Aieta; Pasquale Assalone; Laura Attademo; Antonio Avallone; Francesco Bloise; Davide Bosso; Valentina Borzillo; Giuseppe Buono; Giuseppe Calderoni; Francesca Caputo; Giacomo Cartenì; Diletta Cavallero; Alessia Cavo; Fortunato Ciardiello; Raffaele Conca; Vincenza Conteduca; Stefano De Falco; Marco De Felice; Michelino De Laurentiis; Pietro De Placido; Sabino De Placido; Irene De Santo; Alfonso De Stefano; Carminia Maria Della Corte; Rossella Di Franco; Vincenzo Di Lauro; Antonietta Fabbrocini; Piera Federico; Lucia Festino; Pasqualina Giordano; Mario Giuliano; Cesare Gridelli; Antonio Maria Grimaldi; Michela Lia; Antonella Lucia Marretta; Valentina Massa; Alessia Mennitto; Sara Merler; Valeria Merz; Carlo Messina; Marco Messina; Monica Milano; Alessandro Marco Minisini; Vincenzo Montesarchio; Alessandro Morabito; Floriana Morgillo; Brigitta Mucci; Lucia Nappi; Fabiana Napolitano; Immacolata Paciolla; Martina Pagliuca; Giuseppe Palmieri; Sara Parola; Stefano Pepe; Angelica Petrillo; Francovito Piantedosi; Luisa Piccin; Fernanda Picozzi; Erica Pietroluongo; Sandro Pignata; Veronica Prati; Vittorio Riccio; Mario Rosanova; Alice Rossi; Anna Russo; Massimiliano Salati; Giuseppe Santabarbara; Andrea Sbrana; Ester Simeone; Antonia Silvestri; Massimiliano Spada; Paolo Tarantino; Paola Taveggia; Federica Tomei; Tortora Vincenzo; Dario Trapani; Claudia Trojanello; Vito Vanella; Sabrina Vari; Jole Ventriglia; Maria Grazia Vitale; Fabiana Vitiello; Caterina Vivaldi; Claudia von Arx; Francesca Zacchi; Ilaria Zampiva; Andrea Zivi; Bruno Daniele; Paolo Antonio Ascierto
Journal:  J Immunother Cancer       Date:  2020-10       Impact factor: 13.751

3.  Overlap of immunotherapy-related pneumonitis and COVID-19 pneumonia: diagnostic and vaccine considerations.

Authors:  Muhammad Bilal Abid
Journal:  J Immunother Cancer       Date:  2021-04       Impact factor: 13.751

4.  Case Report: Severe COVID-19 Pneumonia in a Patient With Relapsed/Refractory Hodgkin's Lymphoma.

Authors:  Ipek Yonal-Hindilerden; Fehmi Hindilerden; Metban Mastanzade; Tarik Onur Tiryaki; Sevim Tasan-Yenigun; Yusuf Bilen; Selcuk Aksoz; Arif Atahan Cagatay; Meliha Nalcaci
Journal:  Front Oncol       Date:  2021-03-18       Impact factor: 6.244

5.  Oncologic immunomodulatory agents in patients with cancer and COVID-19.

Authors:  Justin Jee; Aaron J Stonestrom; Sean Devlin; Teresa Nguyentran; Beatriz Wills; Varun Narendra; Michael B Foote; Melissa Lumish; Santosha A Vardhana; Stephen M Pastores; Neha Korde; Dhwani Patel; Steven Horwitz; Michael Scordo; Anthony F Daniyan
Journal:  Sci Rep       Date:  2021-03-01       Impact factor: 4.379

6.  Early immunomodulators with CAR T-cell immunotherapy in the COVID-19 era.

Authors:  Muhammad Bilal Abid
Journal:  Lancet Oncol       Date:  2022-01       Impact factor: 41.316

7.  Transient disappearance of CD19+/CD5+ B-lymphocyte clone in peripheral blood in a patient with CLL during SARS-CoV-2-related mild disease.

Authors:  Remo Barnabei; Giulio Di Michele; Antonio Cellini; Gianfranco Amicosante; Mariagrazia Perilli; Pierangelo Bellio; Alessandra Piccirilli; Giuseppe Celenza
Journal:  Clin Case Rep       Date:  2021-06-22

Review 8.  Potential protective role of the anti-PD-1 blockade against SARS-CoV-2 infection.

Authors:  Annoor Awadasseid; Qiang Yin; Yanling Wu; Wen Zhang
Journal:  Biomed Pharmacother       Date:  2021-07-28       Impact factor: 6.529

Review 9.  Cancer and COVID-19: Why are cancer patients more susceptible to COVID-19?

Authors:  Saptarshi Sinha; Chanakya Nath Kundu
Journal:  Med Oncol       Date:  2021-07-24       Impact factor: 3.064

10.  Italian survey on managing immune checkpoint inhibitors in oncology during COVID-19 outbreak.

Authors:  Marco Tagliamento; Francesco Spagnolo; Francesca Poggio; Davide Soldato; Benedetta Conte; Tommaso Ruelle; Emanuela Barisione; Andrea De Maria; Lucia Del Mastro; Massimo Di Maio; Matteo Lambertini
Journal:  Eur J Clin Invest       Date:  2020-07-05       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.